| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |